aPL and stroke in young women: More fuel for the stroke risk fire

Stroke

Volumn 33, Issue 10, 2002, Pages 2400-2401

  Tuhrim, Stanley ^a   Levine, Steven R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LUPUS ANTICOAGULANT; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADOLESCENT; ADULT; ANTIBODY TITER; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNIZATION; INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FAMILY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; STROKE; SYPHILIS SEROLOGY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; EPIDEMIOLOGY; RISK;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; CAUSALITY; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; ODDS RATIO; RISK; RISK FACTORS;

EID: 0036781795     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Tuhrim S, Rand JH, Wu X-X, Weinberger J, Horowitz DR, Goldman ME, Godbold JH. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke. 1999;30:1561-1565.
2. 2-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program. Stroke. 2001;32:1701-1706.
3. Brey RL, Stallworth CL, McGlasson D, Wozniak MA, Wityk RJ, Stem BJ, Sloan MA, Sherwin R, Price TR, Macko RF, et al. Antiphospholipid antibodies and stroke in young women. Stroke 2002;33: this issue.
4. Tanne D, D'Olhaberriague L, Schultz LR, Salowich-Pal, Sawaya KL, Levine SR. Anticardiolipin antibodies and their associations with cerebrovascular risk factors. Neurology. 1999;52:1368-1373.
5. Gharavi AE, Pierangeli SS, and Harris EN. Origin of antiphospholipid antibodies. Rheum Dis Clin North Am. 2001;27:551-563.
6. The Antiphospholipid Antibodies, and Stroke Study Group (APASS). Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology. 1997;48:91-94.
7. Levine SR for the APASS Study Group. Antiphospholipid antibodies and recurrent thrombo-occlusive events: the Antiphospholipid Antibodies and Stroke Study (APASS). Neurology. 2002;58(suppl 3):A257-A258.